Keith Kennedy's most recent trade in Caredx Inc was a trade of 77,195 Common Stock done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caredx Inc | Keith Kennedy | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 77,195 | 147,296 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | Keith Kennedy | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 100,651 | 100,651 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Keith Kennedy | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 70,101 | 70,101 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Keith Kennedy | COO / CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 02 Mar 2021 | 5,783 | 116,858 (0%) | 0% | 62.1 | 359,413 | Common Stock |
| Veracyte Inc | Keith Kennedy | COO / CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Keith Kennedy | COO / CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 15,000 | 122,641 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Keith Kennedy | COO / CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.30 per share. | 24 Feb 2021 | 11,046 | 107,641 (0%) | 0% | 62.3 | 688,166 | Common Stock |
| Veracyte Inc | Keith Kennedy | COO / CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.08 per share. | 02 Dec 2020 | 944 | 118,117 (0%) | 0% | 55.1 | 51,996 | Common Stock |
| Veracyte Inc | Keith Kennedy | COO / CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.16 per share. | 02 Sep 2020 | 1,131 | 119,061 (0%) | 0% | 34.2 | 38,635 | Common Stock |